Research to Advance Vaccine Safety (R01) National Institute of Allergy and Infectious Diseases/NIH/DHHS

Sponsor Website
Program URL
Deadline Dates (ALL) 07-Jan-2017, 05-Feb-2017, 07-Sep-2017, 05-Oct-2016, 07-Jan-2018, 05-Jun-2018, 07-May-2018, 05-Jun-2017, 05-Oct-2017, 07-Sep-2018, 07-May-2017, 05-Feb-2018, 07-Sep-2016
Synopsis SYNOPSIS:

The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) invites applications to support research that will contribute to the overall understanding of vaccine safety. This research opportunity encourages studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems or healthcare databases, or 5) the application of genomic/molecular technologies and systems biology approaches to evaluate vaccine safety. This FOA aligns with the research goals and objectives outlined in the U.S. National Vaccine Plan). This program will use the NIH Research Project (R01) award mechanism.

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s